Structure via PubChem · Public domain (PubChem)
D-Thyroxin
Sign in to saveAlso known as Choloxin®, D-T4, D-thyroxine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine, DT4, Dextrothyroxine, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine
chemische Verbindung
Chemical data
- Formula
- C15H11I4NO4
- Molecular weight
- 776.87 g/mol
- IUPAC name
- (2R)-2-azaniumyl-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1967
- Admin. routes
- oral
- Indications
- cardiovascular disease, Down syndrome
via ChEMBL · EBI
Research
309 papers- THE EFFECTS OF DEXTROTHYROXINE IN DIABETES.California medicine · 1964
- Dextrothyroxine.New York state journal of medicine · 1972
- Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients.The Journal of clinical endocrinology and metabolism · 1979
- Dextrothyroxine for lowering cholesterol.The Medical letter on drugs and therapeutics · 1976
- Adverse effects of hypolipidaemic drugs.Medical toxicology · 1987
via PubMed
Available in 11 languages
via Wikidata sitelinks · CC0